-
<![CDATA[DLL3 Emerges as an Actionable Target in Small Cell Lung Cancer]]>
27 Sep 2025 13:14 GMT
… lurbinectedin (n = 47), topotecan (n = 185), or amrubicin … previously treated small cell lung cancer receiving tarlatamab: results … treatment for small cell lung cancer (SCLC): primary analysis … Tarlatamab in small-cell lung cancer after platinum-based …
-
<![CDATA[Investigational PD-L1 x VEGF-A Bispecific Antibody Demonstrates Strong Overall Response Rate in Phase II Small Cell Lung Cancer Trial]]>
11 Sep 2025 17:43 GMT
… cell lung cancer is the most aggressive type of lung cancer with … with either paclitaxel or topotecan for patients in the … than non-small cell lung cancer. Lung cancer is the second most … Patients With Small-cell Lung Cancer in Combination With Chemotherapy. …
-
First Disclosure of Global Interim Phase 2 Data for BioNTech and Bristol Myers Squibb PD-L1xVEGF-A Bispecific Antibody Pumitamig (BNT327/BMS986545) in Patients with Extensive-Stage Small Cell Lung Cancer Shows Encouraging Antitumor Activity
08 Sep 2025 15:00 GMT
… Lung Cancer in Barcelona. “Small cell lung cancer is the most aggressive type of lung cancer … -stage small cell lung cancer (Cohort 1) … plus paclitaxel, or topotecan in the second- … Lung Cancer
Small cell lung cancer (SCLC) accounts for 15% of all lung cancer …
-
Ifinatamab Deruxtecan Elicits Responses in Previously Treated Extensive-Stage Small Cell Lung Cancer
08 Sep 2025 00:53 GMT
… of Lung Cancer (IASLC) 2025 World Conference on Lung Cancer.1 … in the form of topotecan, amrubicin, or lurbinectedin, … Study of Lung Cancer (IASLC) 2025 World Conference on Lung Cancer; September … with relapsed small cell lung cancer (IDeate-Lung02). Clinical …
-
New Tools for Lung Cancer, Harder Job for Clinicians
13 Aug 2025 18:17 GMT
… was a comparison trial to topotecan and lurbinectedin, and there … brought on by the progressive lung cancer — which sadly is an … have three available in the lung cancer arena. The benefit, side … so important in small cell [lung cancer], where relapse is almost …
-
Greek Researchers Lead Breakthrough Lung Cancer Study
02 Aug 2025 00:20 GMT
… tarlatamab or chemotherapy drugs, including topotecan, lurbinectedin, or amrubicin. Results … planned for World Lung Cancer Day
Coinciding with World Lung Cancer Day on Aug … of immunotherapy in small-cell lung cancer healthcare.
Greek contribution draws …
-
New Trials Advance Treatments for Lymphoma, Lung Cancer and Sarcomas
25 Jul 2025 21:47 GMT
… sarcomas and ALK-positive lung cancer. Several clinical trials have … , or cyclophosphamide plus topotecan in pediatric patients with … Evaluating Neladalkib for Lung Cancer Subset
The first … -positive non-small cell lung cancer, versus Alecensa (alectinib), a …
-
OPC 2025: Key Studies Shaping Lung Cancer Therapy From ASCO 2025
21 Jun 2025 02:01 GMT
… transforming the treatment landscape for lung cancer, offering new hope for patients … with both small cell lung cancer (SCLC) and non-SCLC ( … , which included lurbinectedin (Zepzelca; Jazz), topotecan (Hycamtin; Sandoz), and amrubicin (Calsed; Nippon …
-
Phase III DeLLphi-304 Trial Finds Imdelltra Significantly Extends Survival in Relapsed Small-Cell Lung Cancer
10 Jun 2025 16:07 GMT
… with relapsed small-cell lung cancer (SCLC) compared to … patients with small-cell lung cancer (SCLC) whose disease … small-cell lung cancer has been limited, with topotecan being the … in Relapsed Small Cell Lung Cancer (DeLLphi-304). ClinicalTrials.gov …
-
Feasibility and Safety of Anlotinib Combined with Immune Checkpoint Inhibitors in Patients with Previously Immunotherapy-Treated Extensive-Stage Small Cell Lung Cancer: A Retrospective Exploratory Study
09 Jun 2025 10:12 GMT
… lung cancer.2 Extensive-stage small cell lung cancer … lung cancer: a retrospective cohort study. Transl Lung Cancer Res … of lung cancer--what limits limited disease? Lung Cancer. 2002 … topotecan for second-line treatment of small cell lung cancer. Lung Cancer …
About
© 1995-2025